# A Study of CM350 in Patients With Advanced Solid Tumors

> **NCT05263960** · PHASE1,PHASE2 · RECRUITING · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 248 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** CM350 group1
- **BIOLOGICAL:** CM350 group2
- **BIOLOGICAL:** CM350 group3

## Key facts

- **NCT ID:** NCT05263960
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-21
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2025-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05263960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05263960, "A Study of CM350 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05263960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*